Table 1 Characteristics of participants (n = 27)
Characteristics | |
|---|---|
Demographics | |
Gender: female, n (%) | 22 (81) |
Age (yrs), mean (SD) | 62 (8) |
Anthropometrics | |
Weight, kg mean (SD) | 70 (14) |
Height, cm, mean (SD) | 170 (10) |
BMI, mean (SD) | 24.3 (3.5) |
RA-related characteristics | |
Disease duration (yrs), median (IQR) | 15 (7–30) |
DAS 28, median (IQR)1 | 2.4 (2.2-2.8) |
General health (VAS), 0–100, median (IQR) | 14 (7–25) |
Fatigue (VAS), 0–100, median (IQR) | 19 (6–35) |
Pain (VAS), 0–100, median (IQR) | 19 (7–28) |
Activity limitation (HAQ) 0–3, median (IQR) | 0.379 (0–0.750) |
RA- medication2 | |
Biologics, n (%) | 17 (63) |
DMARD, n (%) | 17 (63) |
NSAID, n (%) | 8 (30) |
Corticosteroids, n (%) | 5 (19) |
Other medication | |
Beta adrenergic antagonists, n (%) | 3 (11) |
Physical activity | |
30 minutes moderate intensity, times/week past year, median(IQR) (n = 26) | 3.1 (2.2-4.0) |
Circuit training, times/week past year, median (IQR) (n = 26) | 1.3 (0.7-1.7) |